............... 66 12.4.6 Safety of Vesigenurtacel -L (Phase 1 and Arm 4 of Phase 2 Only) ................................ .....66 12.4.7 Safety of the Combination of Vesigenurtacel -L and BCG (Arms 1, 2, and 3 of Phase 2 Only) ................................ ................................